Fos-Aprepitant 125mg Tablet
Marketer
Fulford India Ltd
Salt Composition
Aprepitant (125mg)
Overview Fos-Aprepitant 125mg Tablet
Aprepitant (Fos-Aprepitant) 125mg tablets are a prescription medication preventing chemotherapy-induced nausea and vomiting. They also help prevent postoperative nausea and vomiting in adults. Dosage and duration for this medication, taken with or without food, should strictly follow your physician's instructions. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects, often transient, include headache, hiccups, decreased appetite, tiredness, and constipation. Report any concerning side effects immediately. Diarrhea is a potential side effect; increased fluid intake is advisable to avoid dehydration. Dizziness may occur; refrain from driving or tasks demanding concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Before starting this medication, disclose any pregnancy, pregnancy plans, breastfeeding, or kidney/liver conditions to your doctor for appropriate dosage adjustment.
Uses of Fos-Aprepitant 125mg Tablet
Chemotherapy-induced emesis
Major Benefits of Fos-Aprepitant 125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 125mg Fos-Aprepitant tablet whole; do not damage it by chewing, crushing, or breaking. While this medication can be taken with or without food, consistent timing is recommended for optimal effectiveness.
Common Side effects of Fos-Aprepitant 125mg Tablet:
- Headache
- Dizziness
- Hiccup
- Loss of appetite
- Fatigue
- Constipation
- Diarrhea
How to use Fos-Aprepitant 125mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the 125mg Fos-Aprepitant tablet whole; avoid chewing, crushing, or breaking it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Fos-Aprepitant 125mg Tablet works:
Aprepitant (Fos-125mg) tablets counter nausea and vomiting. This antiemetic medication functions by inhibiting neurokinin, a brain chemical triggering these side effects in cancer patients undergoing chemotherapy.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fos-Aprepitant 125mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Aprepitant 125mg tablets (fos-aprepitant formulation) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Fos-Aprepitant 125mg tablets while breastfeeding is likely unsafe. Available data from humans indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 125mg Fos-Aprepitant tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Aprepitant (fosaprepitant) 125mg tablets are considered safe for use in individuals with renal impairment. No dosage modification is necessary for Fosaprepitant 125mg tablets in this patient population.
LiverSAFE IF PRESCRIBED
Aprepitant (fosaprepitant) 125 mg tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Fos-Aprepitant 125mg Tablet :
Should you forget a Fos-Aprepitant 125mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Fos-Aprepitant 125mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine-based phenyl derivative |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Category | Substances that block NK1 receptors |
3,018 People bought this recently
